Applications of magnetic resonance in model systems: Tumor biology and physiology

Neoplasia

Volumn 2, Issue 1-2, 2000, Pages 139-151

  Gillies, Robert J ^a,j   Bhujwalla, Zaver M ^b   Evelhoch, Jeffrey ^c   Garwood, Michael ^d   Neeman, Michal ^e   Robinson, Simon P ^f   Sotak, Christopher H ^g,h   Van Der Sanden, Boudewijn ⁱ  

^a University of Arizona   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g Worcester Polytechnic Institute   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF ARIZONA   (United States)

more..

Author keywords

Magnetic Resonance imaging (MRI); Magnetic Resonance Spectroscopy (MRS); Tumor Metabolism; Tumor Oxygenation; Tumor Perfusion; Tumor pH

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOGEN; CARBON 13; FLUOROURACIL; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE ALBUMIN; LACTIC ACID; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; GLYCOLYSIS; HUMAN; METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGENATION; PRIORITY JOURNAL; REVIEW; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

EID: 0034006104     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900076     Document Type: Review

References (119)

1. Goldmann E (1907). The growth of malignant disease in man and the lower animals, with special reference to the vascular system. Proc R Soc Med 1, 1-13.
2. Algire GH, Chalkley HW, Legallais FY, and Park HD (1945). Vascular Reactions of normal and malignant tissues in vivo: I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 6, 73-85.
3. Alper T, and Howard-Flanders P (1956). Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 178, 978-979.
4. Thomlinson RH, and Gray LH (1955). The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9, 539-549.
5. Jain RK (1988). Determinants of tumor blood flow: a review. Cancer Res 48, 2641-2658.
6. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324, 1-8.
7. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenal M, Stepniewska K, and Harris AL (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancer 340, 1120-1124.
8. Boehm T, Folkman J, Browder T, and O'Reilly MS (1997). Antiangiogenic therapy of experimental cancer does not induce drug resistance. Nature 390, 404-407.
9. Folkman J, Watson K, Ingber D, and Hanahan D (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61.
10. Moses MA (1991). The Role of Vascularization in Tumor Metastasis. In: Microcirculation in Cancer Metastasis. F William, MR Orr Buchanan and L Weiss (Eds). CRC Press, Boca Raton, FL, pp. 257-276.
11. Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49, 6449-6465.
12. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB 13, 9-22.
13. Gospodarowicz D, Abraham JA, and Schilling J (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci 86, 7311-7315.
14. Ferrara N, and Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-ninding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161, 851-858.
15. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
16. Abramovitch R, Frenkiel D, and Neeman M (1998). Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 39, 813-824.
17. Bhujwalla ZM, Artemov D, and Glockner JF (1999). Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Topics in Magnetic Resonance Imaging, 10.
18. Su M-Y, Wang Z, Carpenter P, Lao X, Muhler A, and Nalcioglu O (1999). Characterization of N-ethyl-N-nitrosurea induced malignant and benign breast tumors in rats using three mR contrast agents. J Magn Reson Imag 9, 177.
19. Schwarzbauer C, Syha J, and Haase A (1993). Quantification of regional blood volume by rapid T1 mapping. Magn Reson Med 29, 709-712.
20. 3-targeted magnetic resonance imaging. Nat Med 4, 623-626.
21. Larcombe McDouall JB, and Evelhoch JL (1990). Deuterium nuclear magnetic resonance imaging of tracer distribution in D2O clearance measurements of tumor blood flow in mice. Cancer Res 50, 363-369.
22. Bernsen HJJA, Rijken PFJW, Oostendorp T, and Van der Kogel AJ (1995). Vascularity and perfusion of human glioma xenografted in the athymic nude mouse. Br J Cancer 71 (4), 721-726.
23. Degani H, Gusis V, Weinstein D, Fields S, and Strano S (1997). Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 13 (7), 780-782.
24. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, and Ohno S (1996). Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200, 639-649.
25. Hulka CA, Edmister WB, Smith BL, Tan L, Sgroi DC, Campbell T, Kopans DB, and Weiskoff RM (1997). Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205, 837-842.
26. Jain RK (1987). Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6, 559-593.
27. Kety SS (1951). The theory and applications of the exchange of inert gas at lungs and tissues. Pharmacol Rev 3, 1-41.
28. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, and Paulson OB (1990). Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 16, 117-131.
29. Tofts PS, and Kermode AG (1991). Measurement of the blood-brain barrier permeability and leakage space using dynamic mr imaging: 1. Fundamental concepts. Magn Reson Med 17, 357-367.
30. Larsson HBW, and Tofts PS (1992). Measurements of blood-brain barrier permeability using dynamic GdDTPA scanning - a comparison of methods. Magn Reson Med 24, 174-176.
31. van der Sanden BPJ, Rozijn TH, Rijken PFJW, HPW Peters, Heerschap A, van der Kogel AJ, and Bovée WMMJ (1999). GdDTPA uptake rates are linearly related to the perfused microvessel density and surface-area in 9L-glioma growing in rat brain. Proc Int Soc Magn Reson Med 7, 147.
32. Bhujwalla ZM, Artemov D, Solaiyappan M, Mao D, and Backer JP (1999). Comparison of vascular volume and permeability for tumors derived from metastatic human breast cancer cells with and without the metastasis suppressor gene nm23. Proc Int Soc Magn Reson Med 7, 146.
33. Artemov D, and Bhujwalla ZM (1997). 3-Dimensional MRI quantitation of tumor vascular volume and permeability. Proc Int Soc Magn Reson Med 5, 491.
34. Braunschweiger P, and Schiffer LM (1986). Effect of dexamethasone on vascular function in RIF-1 tumors. Cancer Res 46, 3299-3303.
35. Furman-Haran E, Margalit R, Grobgeld D, and Degani H (1996). Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc Natl Acad Sci U S A 93, 6247-6251.
36. Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schonberg SO, Vaupel P, and Van Kaick G (1998). Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4, 2305-2312.
37. Pham CD, Roberts TP, Van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, and Brasch RC (1998). Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16, 225-230.
38. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, and Weisskoff RM (1998). NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40, 793-799.
39. Abramovitch R, Meir G, and Neeman M (1995). Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res 55, 1956-1962.
40. Gilead A, and Neeman M (1999). Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. Neoplasia 1 (3), 226-230.
41. Abramovitch R, Marikovsky M, Meir G, and Neeman M (1998). Stimulation of tumor angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 77, 440-447.
42. Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E, and Neeman M (1997). Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci U S A 94, 13203-13208.
43. Robinson SP, Rodrigues LM, Ojugo AS, McSheehy PM, Howe FA, and Griffiths JR (1997). The response to carbogen breathing in experimental tumor models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 75, 1000-1006.
44. Carmeliet P, Dor Y, Herbert J-M, Fukumara D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, and Keshet (1998). E Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394, 485-490.
45. Abramovitch R, Dafni H, Smouha E, Benjamin LE, and Neeman M (1999). In vivo prediction of vascular susceptibility to VEGF withdrawal: MRI of C6 rat glioma in nude mice. Cancer Res, 59, 5012-5016.
46. Benjamin LE, Golijanin D, Itin A, Pode D, and Keshet E (1998). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103, 159-165.
47. Gillies RJ, Schornack PA, Secomb TW, and Raghunand N (1999). Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1 (3), 197-207.
48. 19F NMR of perfluorocarbons. Art Cells, Blood Subs, and Immob Biotech 22, 1141-1153.
49. Ratner AV, Muller HH, Simpson B-B, Johnson DE, Hurd RE, Sotak C, and Young SW (1988). Detection of tumors with 19F magnetic resonance imaging. Invest Radiol 23, 361-364.
50. Sotak CH, Hees PS, Huang H-N, Hung M-H, Krespan CG, and Raynolds S (1993). A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn Reson Med 29, 188-195.
51. Dardzinski BJ, and Sotak CH (1994). Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 32, 88-97.
52. Barker BR, Mason RP, and Peshock RM (1993). Echo planar imaging of perfluoro-carbons. Magn Reson Imaging 11, 1165-1173.
53. Hees PS, and Sotak CH (1993). Assessment of changes in murine tumor oxygenation in response to nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion. Magn Reson Med 29, 303-310.
54. Helmer KG, Han S, and Sotak CH (1998). On the correlation between the water diffusion coefficient and oxygen tension in RIF-1 tumors. NMR Biomed 11, 120-130.
55. Dardzinski BJ, Sotak CH, Isabelle A, Murray J, and Stojadinovic P (1994). Mapping the tissue oxygen tension in RIF-1 tumors following radiation therapy using inversion recovery echo planar imaging and 19F relaxometry of perfluoro-15-crown-5-ether. Proc Int Soc Magn Reson Med 1, 427.
56. Dardzinski BJ, and Sotak CH (1994). Evaluating change in murine tumor oxygenation in response to nicotinamide by using 19F echo-planar imaging and spectroscopy. J Magn Reson Imaging 4, 55.
57. Meiler MR (1999). In vivo characterization of RIF-1 tumors via diffusion and Fluorine-19 NMR methods, PhD Thesis, Worcester Polytechnic Institute.
58. Horsman MR (1998). Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys 42, 701-704.
59. Rojas A (1991). Radiosensitisation with normobaric oxygen and carbogen. Radiother Oncol (Suppl.) 20, 65-70.
60. Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell MEB, Goodchild K, Stratford MRL, and Rojas A (1997). Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer 76, 260-263.
61. Kaanders JHAM, Pop LAM, Marres HAM, Liefers J, Van den Hoogen FJA, Van Daal WAJ, and Van der Kogel AJ (1998). Accelerated radiotherapy with carbogen and nicotinamide (ARGON) for laryngeal cancer. Radiother Oncol 48, 115-122.
62. Robinson SP, Howe FA, Rodrigues LM, Stubbs M, and Griffiths JR (1998). Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow.Semin Radiat Oncol 8, 197-207.
63. Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell MEB, Thoumine M, Caine LA, and Baddeley H (1997). The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39, 697-701.
64. Al-Hallaq HA, River JN, Zamora U, Oikawa H, and Karczmar GS (1998). Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 41, 151-159.
65. 2 using a fibre-optic oxygen sensor in rodent tumors and their response to carbogen breathing. Proc Int Soc Magn Reson Med 3, 1665.
66. 2) and carbon monoxide breathing. Neoplasia 1 (6), 537-543.
67. Robinson SP, Rodrigues LM, Stubbs M, and Griffiths JR (1999). Effects of different levels of hypercapnic hyperoxia on tumor GRE MR image intensity and arterial blood gases. Proc Int Soc Magn Reson Med 7, 1372.
68. Hill SA, Collingridge DR, Vojnovic B, and Chaplin DJ (1998). Tumor radiosensitization by high oxygen content gases: influence of the inspired carbon dioxide content on pO2, microcirculatory function and radiosensitivity. Int J Radiat Oncol Biol Phys 40, 943-951.
69. 31P MRS in rat tumors: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. Br J Cancer 75, 62-68.
70. McSheehy PMJ, Robinson SP, Ojugo ASE, Aboagye EO, Cannell MB, Leach MO, Judson IR, and Griffiths JR (1998). Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. Cancer Res 58, 1185-1194.
71. Warburg O (1956). On the origin of cancer cells. Science 123, 309-314.
72. Wike-Hooley JL, Haveman J, and Reinhold HS (1984). The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2, 343-366.
73. Hwang YC, Kim SG, Evelhoch JL, and Ackerman JJH (1992). Nonglycolytic acidicification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-d-glucose monitored by 1H, 2H, 13C, and 31P magnetic resonance spectroscopy. Cancer Res 52, 1259-1266.
74. 31P NMR spectroscopy. NMR Biomed 3, 233-238.
75. 31P MR spectroscopy. Biochem Pharmacol 57, 309-312.
76. Griffiths JR (1991). Are cancer cells acidic? Br J Cancer 64, 425-427.
77. Stubbs M, Rodrigues L, Howe FA, Wang J, Jeong KS, Veech RL, and Griffiths JR (1994). Metabolic consequences of a reversed pH gradient in rat tumors. Cancer Res 54, 4011-4016.
78. LeBoeuf RA, and Kerckaert GA (1987). Enhanced morphological transformation of early passage syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8, 689-697.
79. LeBoeuf RA, Lin P, Kerckaert G, and Gruenstein E (1992). Intracellular acidification is associated with enhanced morphological transformation in syrian hamster embryo cells. Cancer Res 52, 144-148.
80. Morita T, Nagaki T, Fukuda I, and Okumura K (1992). Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 268, 297-305.
81. Morita T, Takeda K, and Okumura K (1990). Evaluation of clastogenicity of formic acid, acetic acid, and lactic acid on cultured mammalian cells. Mutat Res 240, 195-202.
82. Martinez-Zaguilan R, Seftor EA, Seftor REB, Chu YW, Gillies RJ, and Hendrix MJC (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14, 176-186.
83. Schlappack OK, Zimmermann A, and Hill RP (1991). Glucose starvation and acidosis: effect on experimental metastasic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer 64, 663-670.
84. Montcourrier P, Silver I, Farnoud R, Bird I, and Rochefort H (1995). Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis 15, 382-392.
85. Rozhin J, Sameni M, Ziegler G, and Sloane BF (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 54, 6517-6525.
86. Cuvier C, Jang A, and Hill RP (1997). Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+B) secretion. Clin Exp Metastasis 15, 19-25.
87. Jang A, and Hill RP (1997). An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 15, 469-483.
88. Stubbs M, Bhujwalla ZM, Tozer GM, Rodrigues LM, Maxwell RJ, Morgan R, Howe FA, and Griffiths JR (1992). An assessment of 31P MRS as a method of measuring pH in rat tumors. NMR Biomed 5, 351-359.
89. Taylor JS, and Deutsch C (1983). Fluorinated-methylamino acids as 19-F NMR indicators of intracellular pH. Biophys J 43, 261-267.
90. Mason RP (1999). Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives. Curr Med Chem 6 (6), 481-499.
91. Aoki Y, Akagi K, Tanaka Y, Kawai J, and Takahashi M (1996). Measurement of intratumor pH by pH indicator used in 19F-magnetic resonance spectroscopy. Measurement of extracellular pH decrease caused by hyperthermia combined with hydralazine. Invest Radiol 31 (11), 680-689.
92. Gillies RJ, Liu Z, and Bhujwalla ZM (1994). 31P MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 267 (36), C195-C203.
93. Van Sluis R, Bhujwalla Z, Raghunand N, Ballesteros P, Alvarez J, Cerdan S, and Gillies RJ (1999). Imaging of extracellular pH of tumors using 1H MRSI. Magn Reson Med 41, 743-750.
94. Zhang S, Wu K, and Sherry AD (1999). A novel pH-sensitive MRI contrast agent. Angew Chem, Int Ed Engl, in press.
95. Ward KM, and Balaban RS (1999). Determination of pH using water proton chemical exchange: potential pH sensitive MRI contrast agents. Proc Int Soc Magn Reson Med 7, 1197.
96. Rowland IJ, Murphy PS, Schwarz A, Botta M, Aime S, and Leach MO (1998). In vivo extracellular pH mapping at 1.5 T using proton CSI. Proc Int Soc Magn Reson Med 6, 54.
97. Beauregard DA, Parker D, and Brindle KM (1998). Relaxation-based mapping of tumour pH. Proc Int Soc Magn Reson Med 6, 53.
98. Evelhoch JL, Sapareto SA, Nussbaum GH, and Ackerman JJH (1986). Correlation between 31P NMR spectroscopy and 15O perfusion measurements in the RIF1 murine tumor in-vivo. Radiat Res 106, 122-131.
99. Terpstra M, High WB, dGRA LY, Merkte H, and Garwood M (1996). Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. NMR Biomed 9, 185-194.
100. Bhujwalla ZM, Shungu DC, and Glickson JD (1996). Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging. Magn Reson Med 36, 204-211.
101. Tozer GM, Bhujwalla ZM, Griffiths JR, and Maxwell RJ (1989). Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys 16, 155-164.
102. Bhujwalla ZM, and Glickson JD (1996). Detection of tumor response to radiation therapy by in vivo proton MR spectroscopy. Int J Radiat Oncol Biol Phys 36 (3), 635-639.
103. Bhujwalla ZM, McCoy CL, Glickson JD, Gillies RJ, and Stubbs M (1998). Non-invasive measurements of intra- and extracellular spaces and pH of tumors, before and after 5-fluorouracil, by 31P MR spectroscopy. Br J Cancer 606-611.
104. Aboagye EO, Bhujwalla ZM, Shungu DC, and Glickson JD (1998). Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Res 58, 1063-1067.
105. Schwickert G, Walenta S, Sundfor K, Rofstad EK, and Mueller-Klieser W (1995). Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55, 4757-4759.
106. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, and Mueller-Klieser W (1997). Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150, 409-415.
107. Hurd RE, and Freeman DM (1989). Metabolite specific proton magnetic resonance imaging. Proc Natl Acad Sci U S A 86, 4402-4406.
108. De Graaf AA, Luyten PR, Den Hollander JA, Heindel W, and Bovee WMMJ (1993). Lactate imaging of the human brain at 1.5 T using a double-quantum filter. Magn Reson Med 30, 231-235.
109. 1H MRS. Magn Reson Med 30, 18-27.
110. He Q, Shungu DC, Van Zijl PCM, Bhujwalla ZM, and Glickson JD (1995). Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. J Magn Reson, Ser B 106, 203-211.
111. De Graaf RA, Luo Y, Terpstra M, and Garwood M (1995). Spectral editing with adiabatic pulses. J Magn Reson, Ser B 109, 184-193.
112. Terpstra M, High WB, Luo Y, de Graaf RA, Merkle H, and Garwood M (1996). Relationships among lactate concentration, blood flow, and histopathologic profiles in rat C6 glioma. NMR Biomed 9, 185-194.
113. 1H magnetic resonance spectroscopy study. NMR Biomed 1, 20-26.
114. Lyon RC, Tschudin RG, Daly PF, and Cohen JS (1988). A versatile multinuclear probe designed for in vivo NMR spectroscopy: applications to subcutaneous human tumors in mice. Magn Reson Med 6, 1-14.
115. 13C NMR spectroscopy of glucose metabolism of RIF-1 tumors. Magn Reson Med 20, 17-26.
116. Ronen SM, Volk A, and Mispelter J (1994). Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors. NMR Biomed 7, 278-286.
117. 13C}-glucose metabolism in tumors by hetero-nuclear cross polarization. Magn Reson Med 33, 151-155.
118. Terpstra M, Gruetter R, High WB, Mescher M, DelaBarre L, Merkle H, and Garwood M (1998). Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 58, 5083-5088.
119. 13C] glucose incubation. Eur J Biochem 217, 457-468.